Understanding Cerebral Blood Flow Dynamics for Alzheimer's Disease Prevention Through Acute Exercise (flADex): Protocol for a Randomized Crossover Trial
Open Access
- 31 October 2025
- journal article
- clinical trial-protocol
- Published by Wiley in Brain and Behavior
- Vol. 15 (11) , e70636
Abstract
Introduction: Alzheimer's disease (AD) is a leading cause of disability worldwide. Alterations in cerebral blood flow (CBF) and AD blood biomarkers are fundamental at early stages of AD. Exercise shows promise in delaying physiological changes, but its mechanisms for enhancing brain health remain unclear. flADex aims to examine the acute effects of different exercise types on CBF and blood biomarkers in older adults. This protocol describes the methodology and rationale of flADex. Methods: flADex is a counterbalanced crossover trial in 20 older adults, aged 68–83 years old, with negative brain amyloid status (< 12 centiloid) who are APOEε4 noncarriers. Participants will complete a 30‐min session of each condition in a randomized order: (i) moderate‐intensity aerobic exercise (60%–70% age‐predicted maximal heart rate), (ii) moderate‐intensity resistance exercise (rating of perceived exertion: 4–6 points out of 10), and (iii) resting condition. Changes in CBF are the primary outcome and will be assessed by magnetic resonance imaging using pseudo‐continuous arterial spin labeling at pre‐ and at 3 timepoints post‐condition (starting at 20, 27, 34 min). Secondary outcomes are biomarkers of AD pathology and neurodegeneration (Aβ42, Aβ40, p‐tau217, p‐tau181, BD‐tau, GFAP, NfL) and growth factors (BDNF, IGF‐1), measured through blood samples collected at pre‐ and post‐condition (at 3, 50, 70 min). Moreover, cognitive outcomes and mood status will be measured pre‐ and post‐condition. Conclusion: flADex will highlight the acute effects of different exercise types on CBF and biomarkers before beta‐amyloid accumulation. Acute effects on CBF dynamics and blood biomarkers are expected to be greater with aerobic than resistance exercise when compared to resting. CBF is expected to vary by brain region, and biomarkers to fluctuate dynamically postexercise. This will provide critical insights into exercise's impact on vascular and molecular pathways associated with AD pathology and potential recommendations for standardized blood sampling to enhance diagnostic accuracy.Keywords
This publication has 40 references indexed in Scilit:
- Impact of a Single Bout of Aerobic Exercise on Regional Brain Perfusion and Activation Responses in Healthy Young AdultsPLOS ONE, 2014
- The Pathobiology of Vascular DementiaNeuron, 2013
- II. NIH TOOLBOX COGNITION BATTERY (CB): MEASURING EXECUTIVE FUNCTION AND ATTENTIONMonographs of the Society for Research in Child Development, 2013
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical TrialsAnnals of Internal Medicine, 2013
- Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersNature Reviews Neuroscience, 2011
- Measuring enjoyment of physical activity in older adults: invariance of the physical activity enjoyment scale (paces) across groups and timeInternational Journal of Behavioral Nutrition and Physical Activity, 2011
- An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrusProceedings of the National Academy of Sciences, 2007
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the ratNeuroscience, 2003
- After Reaching Retirement Age Physical Activity Sustains Cerebral Perfusion and CognitionJournal of the American Geriatrics Society, 1990